Healthcare, Pharma & Life Sciences

Moore Named Brand Agency of Record for Alzheimer's Association

Image
Moore Named Brand Agency of Record for Alzheimer's Association

Washington – September 25, 2026 -- Moore has been named brand agency of record for the Alzheimer's Association, expanding an existing fundraising mandate to now cover strategy, creative and media across the health organization's master brand.

Moore expands scope beyond fundraising into full brand management

The appointment follows a competitive review process and grants Moore oversight of all brand creative development, paid media planning and delivery, and marketing across the Association's master brand and national initiatives. The agency will also support select medical and scientific research communications, product launches, and campaigns aimed at reinforcing the Association's position in brain health.

81% of Senior Living Execs Report Rising Resident Acuity: Sage Report

Image
81% of Senior Living Execs Report Rising Resident Acuity: Sage Report

New York – September 25, 2026 -- Eighty-one percent of senior living executives say resident acuity has increased over the past two years, according to a new report from Sage, an integrated Care Intelligence Platform for senior living and skilled nursing. The findings, unveiled at Sage's caregiving summit Sage Shift, draw on a survey of 510 senior living executives, community leaders and caregivers conducted between July 9 and September 25, 2026, alongside operational data from communities running Sage's platform.

Atossa CEO Quay to Join Harvard Panel on Aging Drug Development

Image
Atossa CEO Quay to Join Harvard Panel on Aging Drug Development

Seattle – September 25, 2026 -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) announced that President and CEO Steven Quay, M.D., Ph.D., will serve as a panelist at the 13th Aging Research and Drug Discovery Meeting (ARDD 2026), scheduled for October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University in Boston.

Quay joins regulatory and academic leaders to discuss clinical pathways for aging-related diseases

The panel, titled "Clinical Trials in Diseases of Aging: From Evidence to New Therapeutics and Regulatory Pathways," is set for Thursday, September 25, 2026, from 11:20 a.m. to 12:00 p.m. ET. The session will be moderated by Sebastien Thuault, Editor at Nature Medicine, and will include Jill Lee, Director of Regulatory Policy & Intelligence at Novo Nordisk; Calum MacRae, Professor at Mass General Brigham; and Steve Horvath, Professor at UCLA.

Leapfrog Group Names Retired Navy VADM Raquel Bono Board Chair

Image
Leapfrog Group Names Retired Navy VADM Raquel Bono Board Chair

Washington – September 25, 2026 -- The Leapfrog Group, a national watchdog organization of employers and other health care purchasers, has elected Raquel Bono, MD, MBA, FACS, as its new Board Chair, marking the first time a surgeon has led the nonprofit's board.

Retired Navy Vice Admiral brings $50 billion health system oversight to Leapfrog's board

Dr. Bono is a board-certified trauma surgeon and retired three-star Vice Admiral in the U.S. Navy, where she served as the 11th Chief of the Navy Medical Corps. From 2015 to 2019, she directed the Defense Health Agency, overseeing integration of a $50 billion global health system serving millions of service members and their families.

Minaris, Asimov Partner to Boost AAV Gene Therapy Production Titers

Image
Minaris, Asimov Partner to Boost AAV Gene Therapy Production Titers

Philadelphia and Boston – September 25, 2026 -- Minaris, a global cell and gene therapy CDMO, has partnered with synthetic biology firm Asimov to integrate proprietary OXGENE viral vector technology into Asimov's AAV Edge producer cell lines, targeting higher manufacturing titers and improved product quality for adeno-associated virus (AAV) gene therapies.

Stable production systems aim to replace costly transient manufacturing

Most AAV programs currently rely on transient production, requiring multiple GMP plasmids to be transfected for every batch. This method drives up costs, limits scalability, and can produce inconsistent product quality. Stable production systems have historically been difficult to develop due to the complexity and interdependency of viral genetics involved.

MDpanel Names Nariwal COO, Andrews Chief Client Officer

Image
MDpanel Names Nariwal COO, Andrews Chief Client Officer

Los Angeles – September 25, 2026 -- MDpanel, one of the largest providers of expert medical opinions in the United States, has appointed Manish Nariwal as Chief Operating Officer and Jim Andrews as Chief Client Officer, both reporting to Chairman and CEO Jason Erdell.

Pomdoctor Bets on Hardware-AI-Payment Model for Digital Health

Guangzhou – September 25, 2026 -- Pomdoctor Limited (NASDAQ: POM) outlined a differentiated "hardware plus AI plus payment" infrastructure model that it says sets the company apart from traditional internet healthcare platforms, which typically operate in silos around discrete services such as online consultations or pharmaceutical transactions.

Pomdoctor targets full-cycle predictive healthcare integration

The Guangzhou-based digital healthcare company said its system is designed to combine continuous health monitoring, AI-powered analysis, physician intervention, healthcare payment and fulfillment into a single closed-loop ecosystem, rather than offering standalone services.

Basecamp Research Raises $140M to Advance AI-Designed Cell Therapies

Image
Basecamp Research Raises $140M to Advance AI-Designed Cell Therapies

London and Boston – September 25, 2026 -- Basecamp Research has closed a $140 million oversubscribed Series C financing to train new EDEN foundation models and push a pipeline of AI-designed therapeutics toward clinical development.

S32 leads a syndicate spanning NVIDIA, Anthropic-adjacent backers and sovereign funds

The round was led by S32, with participation from NVIDIA, Menlo Ventures' Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI and True Ventures. Andy Conrad, General Partner at S32 and former CEO of Google's Verily, joins Basecamp's Board of Directors.

Clywedog's Balomenib Cuts HbA1c 0.77% Three Months Post-Dosing

Image
Clywedog's Balomenib Cuts HbA1c 0.77% Three Months Post-Dosing

Dover, Del. – September 25, 2026 -- Clywedog Therapeutics, Inc. reported that its investigational menin inhibitor balomenib produced a placebo-adjusted mean HbA1c reduction of 0.77% at Week 12 (p0.01) and 0.70% at Week 16 (p0.05) in a Phase 1b trial, effects recorded three months after the drug's final dose following just three weeks of treatment.

ISPE Sets October Washington Summit With Lonza, Lilly CEOs Headlining

Image
ISPE Sets October Washington Summit With Lonza, Lilly CEOs Headlining

North Bethesda, Md. – September 24, 2026 -- The International Society for Pharmaceutical Engineering (ISPE) will convene its 2026 Annual Meeting & Expo in Washington, D.C. from October 18-21, drawing pharmaceutical manufacturing leaders for four days of hybrid sessions combining in-person and virtual attendance.

Lonza and Eli Lilly executives headline keynote lineup on manufacturing innovation

Wolfgang Wienand, PhD, CEO of Lonza, will present "The Lonza Engine: Manufacturing the Medicines of Tomorrow," while Kevin Trivett, Senior Vice President of Device and Packaging Operations Manufacturing at Eli Lilly and Company, delivers "Lilly: Embracing Technology to Reach Patients." Additional featured speakers include Marla Phillips, PhD, CEO and President of Pathway for Patient Health LLC, addressing AI and human oversight in manufacturing loops, and cancer survivor and research advocate Jamie Valvano.